Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1093943003
Since 2009
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5501 Old York Rd, Albert Einstein Medical Center, Levy 8th Floor
Philadelphia, PA, 19141
Phone (215) 456-6006
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
192 services
Medicare patients, 2024
107
Average age 70
Drug cost, 2024
$1.5M
868 prescriptions
Company payments, 2025
$143
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aparna M Prabhu was code 95886 (electrical nerve conductivity), 41 times for 20 patients. In total Aparna M Prabhu billed 192 services in 21 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 41 | 20 | $37.01 | $1,518 |
| 99233 Hospital E&M - Subsequent | Facility | 33 | 25 | $101.27 | $3,342 |
| 99222 Hospital E&M - Initial | Facility | 19 | 19 | $111.65 | $2,121 |
| 99215 Office E&M - Established | Facility | 17 | 15 | $118.26 | $2,011 |
| 99232 Hospital E&M - Subsequent | Facility | 13 | 11 | $67.25 | $874 |
| 95911 Electrical Nerve Conductivity | Facility | 13 | 13 | $110.98 | $1,443 |
| 99214 Office E&M - Established | Facility | 11 | 11 | $67.89 | $747 |
By year: 2022 $22K for 247 services; 2023 $16K for 190 services; 2024 $16K for 192 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aparna M Prabhu prescribed most often to Medicare patients was Baclofen, with 80 prescriptions and refills. In total Aparna M Prabhu wrote 868 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 80 | 119 | 16 | $1,178 |
| Gabapentin Generic | 79 | 91 | 14 | $782 |
| Dalfampridine Er Dalfampridine | 71 | 71 | Under 11 | $31K |
| Myrbetriq Mirabegron | 55 | 59 | Under 11 | $26K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 42 | 50 | Under 11 | $321 |
| Dimethyl Fumarate Generic | 37 | 37 | Under 11 | $168K |
| Ampyra Dalfampridine | 33 | 37 | Under 11 | $146K |
| Pregabalin Generic | 32 | 32 | Under 11 | $482 |
| Kesimpta Pen Ofatumumab | 32 | 32 | Under 11 | $312K |
| Vumerity Diroximel Fumarate | 25 | 25 | Under 11 | $222K |
| Tizanidine Hcl Generic | 25 | 27 | Under 11 | $286 |
| Levetiracetam Generic | 24 | 34 | Under 11 | $798 |
| Rebif Rebidose Interferon Beta-1a/Albumin | 24 | 24 | Under 11 | $240K |
| Lacosamide Generic | 20 | 20 | Under 11 | $2,816 |
| Mirtazapine Generic | 17 | 25 | Under 11 | $188 |
Brand drugs: 227 claims; generic drugs: 641 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aparna M Prabhu $143 ($143 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $93.02.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.